載入...
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection
The herpes simplex type 2 (HSV-2) envelope glycoprotein (gD2) was evaluated as a potential antigen candidate for a plasmid DNA (pDNA)-based HSV-2 vaccine. The pDNA was formulated with Vaxfectin, a cationic lipid-based adjuvant, and tested in a murine HSV-2 lethal challenge model. gD2 was expressed a...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Society for General Microbiology
2012
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755514/ https://ncbi.nlm.nih.gov/pubmed/22398318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/vir.0.040055-0 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|